直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

Imminent Tillis Bill Expands Eligibility, Protects Diagnostics

August 1, 2022

Law360

A new bill to codify exceptions to patent eligibility will override case law that is unclear about what inventions are considered abstract and also made it difficult to receive patents on diagnostics. Under the proposed Patent Eligibility Restoration Act of 2022, inventions with technological components would be patent eligible, while only some exclusions would be enforced. The new approach would be more in line with the way in which Europe handles patent eligibility. Law360 interviewed Finnegan partner Maeve O’Flynn for her thoughts on how codified exclusions have impacted patent eligibility in Europe.

Maeve said, “Generally, we know where we are in Europe. That gives you a certain amount of certainty about what you need to get a patent.”

Read “Imminent Tillis Bill Expands Eligibility, Protects Diagnostics”

Tags

patent-eligible

Related Practices

Patent Drafting and Prosecution

Related Offices

London

Related Professionals

Maeve O'Flynn
Partner
London
+44 (0)20 7864 2856
Email

Related News

Award/Ranking

Finnegan Recognized Again Among Germany’s Leading Law Firms

October 9, 2026

Press Release

Finnegan Secures Summary Determination of No Violation in ITC Vehicle Space Guards Investigation for Drop Stop

October 6, 2026

Award/Ranking

Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027

September 24, 2026

Press Release

Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower

September 23, 2026

Award/Ranking

Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026

September 23, 2026

Commentary

FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics

September 20, 2026

Commentary

Jellycat’s ‘Dupe’ Dilemma: Can IP Protect a ‘Cute’ Aesthetic?

September 16, 2026

Award/Ranking

Finnegan Wins “Hatch-Waxman Litigation Firm of the Year – Branded” and David Weingarten Wins “Patent Strategy Attorney of the Year (South)” at the LMG Life Sciences Americas Awards

September 11, 2026

Press Release

Finnegan Expands U.S. Platform with Launch of Dallas Office

September 2, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP